Cite
MLA Citation
Yingkun Xu et al.. “Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.” BioMed research international, vol. 2022, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100164964864.0x000002